3 research outputs found
DielsāAlder Reactions of 9āFerrocenyl- and 9,10-Diferrocenylanthracene: Steric Control of 9,10- versus 1,4-Cycloaddition
Cycloadditions
of benzynes, <i>N</i>-methyl- or <i>N</i>-phenylmaleimide,
dimethyl acetylenedicarboxylate, and benzoquinone to 9-ferrocenylanthracene
(<b>1</b>) and 9,10-diferrocenylanthracene (<b>2</b>)
are described. Benzyne and 3-fluorobenzyne add to <b>1</b> and <b>2</b> to form the corresponding 9-ferrocenyl- or 9,10-diferrocenyltriptycenes;
in contrast, bulkier benzynes such as 3-trifluoromethylbenzyne preferentially
add to <b>2</b> across C<sub>1</sub> and C<sub>4</sub> to form
6,11-diferrocenyl-5,12-etheno-5,12-dihydrotetracenes. The maleimides
undergo DielsāAlder reactions with <b>1</b> to form the
9-ferrocenylbarrelenes <b>10</b> and <b>11</b>, but cycloaddition
to <b>2</b> occurs not only across C<sub>9</sub> and C<sub>10</sub> to form the barrelene <b>13</b> but also across C<sub>1</sub> and C<sub>4</sub> to yield ethenoanthracenes as both endo and exo
adducts, <b>14</b> and <b>15</b>, respectively. Likewise,
DMAD forms 11,12-dicarbomethoxy-9-ferrocenylbarrelene (<b>16</b>) with <b>1</b> but reacts with <b>2</b> by addition
across C<sub>1</sub> and C<sub>4</sub> to form <b>17</b>. Hydrolysis
of <b>16</b> cleaves only the ester distant from the ferrocenyl
group. Treatment of the DielsāAlder adduct <b>20</b> of
9-ferrocenylanthracene (<b>1</b>) and benzoquinone with base
and RX (R = Me, Et, CH<sub>2</sub>OMe, CH<sub>2</sub>CO<sub>2</sub>Me) yields the corresponding 1,4-dialkoxy-9-ferrocenyltriptycenes <b>22</b>ā<b>25</b>. The factors influencing the regiochemistry
of the cycloadditions are discussed, and several examples of each
reaction type have been characterized by X-ray crystallography
High and Low Rotational Barriers in Metal Tricarbonyl Complexes of 2- and 3āIndenyl Anthracenes and Triptycenes: Rational Design of Molecular Brakes
Syntheses and X-ray crystal structures are reported for
a series
of MĀ(CO)<sub>3</sub> derivatives (M = Cr, Re) of phenyl and also 2-
and 3-indenyl anthracenes and triptycenes. In each case, the rotational
barrier about the bond linking the two organic fragments was evaluated
both experimentally by VT or 2D-EXSY NMR and by calculation at the
DFT level. Attachment of the metal tripod to the indenyl moiety in
an Ī·<sup>6</sup> fashion does not markedly change the barrier
relative to that for the free ligand but lowers the symmetry so as
to facilitate its direct measurement. Interestingly, an Ī·<sup>6</sup> ā Ī·<sup>5</sup> haptotropic shift of the CrĀ(CO)<sub>3</sub> moiety in 9-indenylanthracenes led to a somewhat lowered
barrier, probably attributable to an increase in the ground state
energy rather than to decreased steric interactions in the transition
state. In contrast, in indenyltriptycenes Ī·<sup>6</sup> ā
Ī·<sup>5</sup> migration of the MĀ(CO)<sub>3</sub> unit along
the indenyl skeleton and closer to a paddlewheel leads to a very significant
increase in the rotational barrier. These effects can be rationalized
in terms of angular steric strain and multiple interactions in the
ground state and in the transition state. The results not only provide
semiquantitative data on the steric effects of Ī·<sup>6</sup>-phenyl and Ī·<sup>6</sup>- or Ī·<sup>5</sup>-indenyl MĀ(CO)<sub>3</sub> fragments but are also discussed with relevance to their
role in organometallic molecular brakes
A New Series of Succinimido-ferrociphenols and Related Heterocyclic Species Induce Strong Antiproliferative Effects, Especially against Ovarian Cancer Cells Resistant to Cisplatin
Ferrociphenols
are known to display anticancer properties by original
mechanisms dependent on redox properties and generation of active
metabolites such as quinone methides. Recent studies have highlighted
the positive impact of oxidative stress on chemosensitivity and prognosis
of ovarian cancer patients. Ovarian adenocarcinomas are shown to be
an excellent model for defining the impact of selected ferrociphenols
as new therapeutic drugs for such cancers. This work describes the
syntheses and preliminary mechanistic research of unprecedented multitargeting
heterocyclic ferrociphenols bearing either a succinimidyl or phthalimidyl
group that show exceptional antiproliferative behavior against epithelial
ovarian cancer cells resistant to cisplatin. Owing to the failure
of the present pharmaceutical options, such as carboplatin a metallodrug
based on Pt coordination chemistry, these species may help to overcome
the problem of lethal resistance. Currently, ferrociphenolic entities
generally operate via apoptotic and senescence pathways. We present
here our first results in this new cyclic-imide series